Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside.

Microsoft has shown strong AI monetization, but faces slowing enterprise adoption, rising competition, and high valuation risks. Find out why MSFT stock is a hold.

Asking students to identify an example of what something is—and importantly, what it isn’t—helps establish clarity and leaves little room for misconception.

People still tell "Twilight" star Robert Pattinson that the movies and Stephenie Meyer books ruined the vampire genre. But did it? We asked readers.

Johnson Matthey ( ($GB:JMAT) ) has shared an update. Johnson Matthey has announced the reclassification of its Catalyst Technologies segment ...

Together with retail search, brand and display placements, and its demand-side platform (DSP), Amazon is deepening the ways ...

With the rise of renewable energy and electric vehicles, hydrogen-powered vehicles have attracted growing interest. Prof.

(The Center Square) – In addition to expressing profound sorrow for the loss of Turning Point USA founder Charlie Kirk, pastors say they hope his death and life, marked by speaking what they said was ...

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is one of the best biotech stocks with high potential. HC Wainwright reiterated ...